Works matching AU Nagura, Yoshihito

Results: 19
    1

    Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 4, p. 311, doi. 10.1159/000541455
    By:
    • Kato, Daisuke;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Hayashi, Katsumi;
    • Kusakabe, Atsunori;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Mizoshita, Tsutomu;
    • Kimura, Yoshihide;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    2

    Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study.

    Published in:
    Oncology, 2024, v. 102, n. 8, p. 676, doi. 10.1159/000536367
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    3
    4
    5

    Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B.

    Published in:
    PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263844
    By:
    • Nagura, Yoshihito;
    • Matsuura, Kentaro;
    • Iio, Etsuko;
    • Fujita, Koji;
    • Inoue, Takako;
    • Matsumoto, Akihiro;
    • Tanaka, Eiji;
    • Nishiguchi, Shuhei;
    • Kang, Jong-Hon;
    • Matsui, Takeshi;
    • Enomoto, Masaru;
    • Ikeda, Hiroki;
    • Watanabe, Tsunamasa;
    • Okuse, Chiaki;
    • Tsuge, Masataka;
    • Atsukawa, Masanori;
    • Tateyama, Masakuni;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    6
    7

    Serum interleukin‐6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis.

    Published in:
    Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 10, p. 2158, doi. 10.1111/jgh.16672
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Kusakabe, Atsunori;
    • Narahara, Satoshi;
    • Tokunaga, Takayuki;
    • Nagaoka, Katsuya;
    • Murakami, Shuko;
    • Inoue, Takako;
    • Kuroyanagi, Keita;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    8

    Long‐term outcomes of nasogastric tube with Gastrografin for adhesive small bowel obstruction.

    Published in:
    Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 1, p. 111, doi. 10.1111/jgh.15681
    By:
    • Nishie, Hirotada;
    • Shimura, Takaya;
    • Katano, Takahito;
    • Iwai, Tomohiro;
    • Itoh, Keisuke;
    • Ebi, Masahide;
    • Mizuno, Yusuke;
    • Togawa, Shozo;
    • Shibata, Shunsuke;
    • Yamada, Tomonori;
    • Mizushima, Takashi;
    • Inagaki, Yusuke;
    • Kitagawa, Mika;
    • Nojiri, Yu;
    • Tanaka, Yoshito;
    • Okamoto, Yasuyuki;
    • Matoya, Sho;
    • Nagura, Yoshihito;
    • Inagaki, Yuki;
    • Koguchi, Hiroki
    Publication type:
    Article
    9

    Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6876
    By:
    • Takanori Suzuki;
    • Kentaro Matsuura;
    • Yuta Suzuki;
    • Fumihiro Okumura;
    • Yoshihito Nagura;
    • Satoshi Sobue;
    • Sho Matoya;
    • Tomokatsu Miyaki;
    • Yoshihide Kimura;
    • Atsunori Kusakabe;
    • Satoshi Narahara;
    • Takayuki Tokunaga;
    • Katsuya Nagaoka;
    • Keita Kuroyanagi;
    • Hayato Kawamura;
    • Kayoko Kuno;
    • Kei Fujiwara;
    • Shunsuke Nojiri;
    • Hiromi Kataoka;
    • Yasuhito Tanaka
    Publication type:
    Article
    10

    The first management using intubation of a nasogastric tube with Gastrografin enterography or long tube for non-strangulated acute small bowel obstruction: a multicenter, randomized controlled trial.

    Published in:
    2020
    By:
    • Katano, Takahito;
    • Shimura, Takaya;
    • Nishie, Hirotada;
    • Iwai, Tomohiro;
    • Itoh, Keisuke;
    • Ebi, Masahide;
    • Mizuno, Yusuke;
    • Togawa, Shozo;
    • Shibata, Shunsuke;
    • Yamada, Tomonori;
    • Mizushima, Takashi;
    • Inagaki, Yusuke;
    • Kitagawa, Mika;
    • Nojiri, Yu;
    • Tanaka, Yoshito;
    • Okamoto, Yasuyuki;
    • Sugiura, Miyuki;
    • Matoya, Sho;
    • Nagura, Yoshihito;
    • Inagaki, Yuki
    Publication type:
    journal article
    11

    Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents.

    Published in:
    Hepatology Research, 2024, v. 54, n. 1, p. 32, doi. 10.1111/hepr.13962
    By:
    • Nagura, Yoshihito;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Ogawa, Shintaro;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Nagaoka, Katsuya;
    • Iio, Etsuko;
    • Watanabe, Takehisa;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    12

    The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2023, v. 53, n. 6, p. 511, doi. 10.1111/hepr.13886
    By:
    • Matoya, Sho;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kuroyanagi, Keita;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Miyaki, Tomokatsu;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    13

    Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.

    Published in:
    Hepatology Research, 2023, v. 53, n. 4, p. 289, doi. 10.1111/hepr.13864
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Urakabe, Kenji;
    • Okumura, Fumihiro;
    • Kawamura, Hayato;
    • Sobue, Satoshi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Kato, Daisuke;
    • Kusakabe, Atsunori;
    • Tanaka, Yoshito;
    • Ozasa, Atsushi;
    • Nagura, Yoshihito;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Hagiwara, Shinya;
    • Kusumoto, Shigeru;
    • Inoue, Takako;
    • Tanaka, Yasuhito
    Publication type:
    Article
    14

    Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts.

    Published in:
    Hepatology Research, 2023, v. 53, n. 3, p. 267, doi. 10.1111/hepr.13865
    By:
    • Kimura, Yoshihide;
    • Fujiwara, Kei;
    • Matsuura, Kentaro;
    • Suzuki, Takanori;
    • Senoo, Kyouji;
    • Tsuchida, Kenji;
    • Mori, Yoshinori;
    • Hirano, Atsuyuki;
    • Nomura, Satoshi;
    • Kitagawa, Mika;
    • Tomita, Yusaku;
    • Kanaiwa, Hiroki;
    • Imazu, Mitsuki;
    • Nagura, Yoshihito;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    15
    16
    17

    A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.

    Published in:
    PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257166
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Uchida-Kobayashi, Sawako;
    • Takaguchi, Koichi;
    • Tsutsui, Akemi;
    • Nozaki, Akito;
    • Chuma, Makoto;
    • Hidaka, Isao;
    • Ishikawa, Tsuyoshi;
    • Iwasa, Motoh;
    • Tamai, Yasuyuki;
    • Tobari, Maki;
    • Matsuura, Kentaro;
    • Nagura, Yoshihito;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Suzuki, Kenta;
    • Okubo, Tomomi;
    • Arai, Taeang
    Publication type:
    Article
    18

    Adult-onset Still's Disease (AOSD) with Gastrointestinal Lesions.

    Published in:
    Internal Medicine, 2024, v. 63, n. 24, p. 3317, doi. 10.2169/internalmedicine.3412-23
    By:
    • Takahito Harada;
    • Yoshikazu Hirata;
    • Hayato Kawamura;
    • Yuki Yamamoto;
    • Yuka Kobayashi;
    • Daisuke Kumai;
    • Akihisa Adachi;
    • Yoshihito Nagura;
    • Hirokazu Ikeuchi;
    • Noriyuki Hayashi;
    • Hiroki Takada;
    • Satoshi Sobue;
    • Megumi Yoshida
    Publication type:
    Article
    19